Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Antoni

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
PDA Journal of Pharmaceutical Science and Technology|September 2, 2000
Enumeration of total viable microorganisms in an antibiotic raw material using ChemScan solid phase cytometerB Ramond, X Rolland, C Planchez, et al.
Annals of the Rheumatic Diseases|February 15, 2005
OMERACT 7 psoriatic arthritis workshop: synopsisD D Gladman, V Strand, P J Mease, et al.
Rheumatology International|January 1, 1997
NMR monitoring of rheumatoid arthritis patients receiving anti-TNF-alpha monoclonal antibody therapyD Kalden-Nemeth, J Grebmeier, C Antoni, et al.
Rheumatology (Oxford, England)|May 6, 2003
Joint counts in routine practiceD L Scott, C Antoni, E H Choy, et al.
Clinical and Experimental Rheumatology|November 27, 2008
Combination treatment with infliximab and leflunomide in patients with active rheumatoid arthritis: safety and efficacy in an open-label clinical trialJ R Kalden, H G Nüsslein, J Wollenhaupt, et al.
International Journal of Immunopathology and Pharmacology|July 13, 2006
Leukocyte infiltration and mRNA expression of IL-20, IL-8 and TNF-R P60 in psoriatic skin is driven by TNF-alphaA L J Ogilvie, M Lüftl, C Antoni, et al.
The British Journal of Dermatology|March 22, 2001
Treatment of psoriatic arthritis with antitumour necrosis factor-alpha antibody clears skin lesions of psoriasis resistant to treatment with methotrexateA L Ogilvie, C Antoni, C Dechant, et al.
The Journal of Rheumatology|February 24, 2000
In vivo blockade of tumor necrosis factor-alpha in patients with rheumatoid arthritis: longterm effects after repeated infusion of chimeric monoclonal antibody cA2H M Lorenz, M Grünke, T Hieronymus, et al.
Medicine|May 1, 1995
One hundred anti-Ro (SS-A) antibody positive patients: a 10-year follow-upE Simmons-O'Brien, S Chen, R Watson, et al.
Annals of the Rheumatic Diseases|August 13, 2005
Infliximab improves health related quality of life and physical function in patients with psoriatic arthritisA Kavanaugh, C Antoni, G G Krueger, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
PDA Journal of Pharmaceutical Science and Technology|September 2, 2000
Enumeration of total viable microorganisms in an antibiotic raw material using ChemScan solid phase cytometerB Ramond, X Rolland, C Planchez, et al.
Annals of the Rheumatic Diseases|February 15, 2005
OMERACT 7 psoriatic arthritis workshop: synopsisD D Gladman, V Strand, P J Mease, et al.
Rheumatology International|January 1, 1997
NMR monitoring of rheumatoid arthritis patients receiving anti-TNF-alpha monoclonal antibody therapyD Kalden-Nemeth, J Grebmeier, C Antoni, et al.
Rheumatology (Oxford, England)|May 6, 2003
Joint counts in routine practiceD L Scott, C Antoni, E H Choy, et al.
Clinical and Experimental Rheumatology|November 27, 2008
Combination treatment with infliximab and leflunomide in patients with active rheumatoid arthritis: safety and efficacy in an open-label clinical trialJ R Kalden, H G Nüsslein, J Wollenhaupt, et al.
International Journal of Immunopathology and Pharmacology|July 13, 2006
Leukocyte infiltration and mRNA expression of IL-20, IL-8 and TNF-R P60 in psoriatic skin is driven by TNF-alphaA L J Ogilvie, M Lüftl, C Antoni, et al.
The British Journal of Dermatology|March 22, 2001
Treatment of psoriatic arthritis with antitumour necrosis factor-alpha antibody clears skin lesions of psoriasis resistant to treatment with methotrexateA L Ogilvie, C Antoni, C Dechant, et al.
The Journal of Rheumatology|February 24, 2000
In vivo blockade of tumor necrosis factor-alpha in patients with rheumatoid arthritis: longterm effects after repeated infusion of chimeric monoclonal antibody cA2H M Lorenz, M Grünke, T Hieronymus, et al.
Medicine|May 1, 1995
One hundred anti-Ro (SS-A) antibody positive patients: a 10-year follow-upE Simmons-O'Brien, S Chen, R Watson, et al.
Annals of the Rheumatic Diseases|August 13, 2005
Infliximab improves health related quality of life and physical function in patients with psoriatic arthritisA Kavanaugh, C Antoni, G G Krueger, et al.
Pageof 4